3Sakata K, Sakata A, Vela Roch N. Fas (CD95) - transduced signal preferentially stimulates lupus peripheral T lymphocytes. Eur J Immunol,1998,8(7) :2648 - 2660.
4Lefkowith JB, Kiehl M, Rubenstein J, et al. Heterogeneity and clinical significance of glomerular - binding antibodies in systemic lupus erythematosus. J Clin Invest, 1996,98(6) : 1373 - 1380.
5Berden JH, Licht R, Van Bruggen MC, et al. Role of nucleosomes for induction and glomerular - binding of autoantibodies in lupus nephritis.Curt Opin Nephrol Hypertens, 1999,8(3) :299 - 306.
6Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease Ⅰ Pine Natl Acad Sci, 1974,71 (12) :4742 - 4746.
7Puccetti A, Madaio MP, Bellese G, et al. Anti - DNA antibodies bind to DNase I . Exp Med,1995,181(5):1797- 1804.
8Pan CQ, Dodge TH, Baker DL, et al. Improved potency of hyperactive and actin resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus. J Biol Chem, 1998,273(29) : 18374.
9Stohl W, Elliot JE, Lynch DH. CD95(Fas) - based, superantigen - dependent, CD4 + T cell - mediated down - regulation of human in vitro immunoglobulin response. Immunol, 1998,160( 11 ) : 5231 - 5238.
10Casciola Rosen LA, Anhalt G, Rosen A, et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structureson apoptotic keratinocytes. Exp Med, 1994,179(4) : 1317- 1330.
